Three dairy producers to be recognized for demonstrating judicious antibiotic use
Boehringer Ingelheim (BI) is once again accepting applications for its Producers for Progress Recognition Program. The program honors those who have demonstrated commitment to the well-being of their animals through the judicious use of antibiotics.
Applications are due Monday, July 1, 2019, and can be found at Producers4Progress.com or by contacting your BI representative.
The 2018 grand prize winner, Jami Schultze of Maple Ridge Dairy in Stratford, Wisconsin, shares her perspective on judicious antibiotic use: “Consumers are concerned about their food more than ever now. As a dairy farm, it is our job to build trust and be transparent to the consumer, and actively show them we have nothing to hide. If our industry does not continue to improve and show responsible antibiotic usage, we risk having further regulations forced upon us.”
Schultze demonstrates a strong commitment to the future of the dairy industry, and BI aims to continue rewarding those producers going above and beyond to care for their animals through the Producers for Progress Recognition Program.
Applicants will be asked to answer a few open-ended questions about their preventive management practices, their views on judicious use of antibiotics, and to describe their mastitis treatment protocols.
Three dairy producers will then be selected by the judges to receive the Producers for Progress recognition, based on the following criteria:
- Demonstrated understanding of and passion for judicious use of antibiotics;
- Commitment to animal well-being; and
- Being a customer of at least one BI mastitis product.
Applicant names and operations will remain anonymous during judging. Prize recipients will be selected and notified by Thursday, August 15, 2019.
Are you or is someone you know deserving of Producers for Progress recognition? Apply by visiting Producers4Progress.com to fill out the online application form, or contact your local BI representative. Applications are due July 1, 2019.
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long term success rather than short-term profit. The company therefore aims at organic growth from its own resources, with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility toward mankind and the environment.
Boehringer Ingelheim is the second largest animal health business in the world. We are committed to creating animal wellbeing through our large portfolio of advanced, preventive healthcare products and services. With net sales in 2017 of 3.9 billion euros ($4.4 billion) and around 10,000 employees worldwide, we are present in more than 150 markets. For more information, visit here: https://www.boehringer-ingelheim.com/animal-health/overview.
John Deere is a registered trademark of Deere & Company. Bogs is a registered trademark of Bogsfootwear.com. Udder Tech is a registered trademark of Udder Tech, Inc. Deere & Company, Bogsfootwear.com and Udder Tech neither sponsor nor endorse this promotion.